These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 378418)

  • 21. Immune interferon. II. Different cellular site for the production of murine macrophage migration inhibitory factor and interferon.
    Neumann C; Sorg C
    Eur J Immunol; 1978 Aug; 8(8):582-9. PubMed ID: 359337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding characteristics of fluoresceinated Lotus tetragonolobus fucolectin to macrophage populations which are either responsive or refractory to activation by lymphokine.
    Leu RW; Herriott MJ; Webb CF
    Immunobiology; 1985 Apr; 169(3):272-9. PubMed ID: 3888826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current state of studies of mediators of cellular immunity: a progress report.
    Cell Immunol; 1977 Oct; 33(2):233-44. PubMed ID: 334378
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
    Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
    Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage migration inhibition induced by MDP, LPS, PMA, and MIF/MAF: reversal by macrophage migration enhancement factor (MEF), L-fucose, L-fucosyl BSA, D-mannose, and D-mannosyl BSA.
    Gordon MR; Chida K; Takata I; Myrvik QN
    J Leukoc Biol; 1987 Sep; 42(3):197-203. PubMed ID: 3305746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biochemistry and in vitro activity of soluble factors of activated lymphocytes.
    Sorg C
    Mol Cell Biochem; 1979 Dec; 28(1-3):149-67. PubMed ID: 393992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A macrophage surface component related to fibronectin is involved in the response to migration inhibitory factor.
    Remold HG; Shaw JE; David JR
    Cell Immunol; 1981 Feb; 58(1):175-87. PubMed ID: 7013990
    [No Abstract]   [Full Text] [Related]  

  • 28. Macrophage glycolipid receptors for human migration inhibitory factor (MIF): differentiated HL-60 cells exhibit MIF responsiveness and express surface glycolipids which both bind MIF and convert nonresponsive cells to responsiveness.
    Liu DY; Yu SF; Remold HG; David JR
    Cell Immunol; 1985 Feb; 90(2):605-13. PubMed ID: 3881194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory mechanisms of cutaneous delayed-type hypersensitivity. I. Suppression of cutaneous delayed-type hypersensitivity by migration inhibitory factor.
    Mizushima A; Baba T; Ochiya T; Yamaguchi K; Onozaki K; Yaoita H; Uyeno K
    Cell Immunol; 1983 Oct; 81(1):126-33. PubMed ID: 6352055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and characterization of antisera against guinea pig macrophage activating factor.
    Peck R; Talmadge K; Polak L
    Int Arch Allergy Appl Immunol; 1984; 75(4):361-7. PubMed ID: 6389371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycolipid receptor for human migration inhibitory factor: fucose and sialic acid are important for the human monocyte response to migration inhibitory factor.
    Liu DY; Yu SF; Remold HG; David JR
    Cell Immunol; 1985 Feb; 90(2):539-46. PubMed ID: 3917866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of macrophage activation induced by Ca2+ ionophore.
    Onozaki K; Takenawa T; Homma Y; Hashimoto T
    Cell Immunol; 1983 Feb; 75(2):242-54. PubMed ID: 6403251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
    Celada A; Gray PW; Rinderknecht E; Schreiber RD
    J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of heparin on chemotactic and migration inhibitory lymphokines.
    Yoshida T; Amsden A; Ksiazek J; Cohen S
    Clin Immunol Immunopathol; 1978 Jul; 10(3):287-91. PubMed ID: 352595
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of macrophage functions by lymphokines.
    Sorg C
    Immunobiology; 1982 Apr; 161(3-4):352-60. PubMed ID: 6178679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4).
    Roger T; Froidevaux C; Martin C; Calandra T
    J Endotoxin Res; 2003; 9(2):119-23. PubMed ID: 12803886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomes as lymphokine activity indicators in the electrophoretic mobility test.
    Schütt W; Jenssen HL; Werner H; Köhler H
    Acta Biol Med Ger; 1977; 36(2):281-4. PubMed ID: 333836
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular cloning and functional characterization of the avian macrophage migration inhibitory factor (MIF).
    Kim S; Miska KB; Jenkins MC; Fetterer RH; Cox CM; Stuard LH; Dalloul RA
    Dev Comp Immunol; 2010 Sep; 34(9):1021-32. PubMed ID: 20470818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane glycolipids and human immunodeficiency virus infection of primary macrophages.
    Seddiki N; Ben Younes-Chennoufi A; Benjouad A; Saffar L; Baumann N; Gluckman JC; Gattegno L
    AIDS Res Hum Retroviruses; 1996 May; 12(8):695-703. PubMed ID: 8744580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.